172 related articles for article (PubMed ID: 35474665)
21. [Management of malignant ureteral obstruction.].
Jaunarena JH; Cristallo C; González MS; Daels FP; De la Rosette J; Laguna MP
Arch Esp Urol; 2016 Oct; 69(8):507-517. PubMed ID: 27725327
[TBL] [Abstract][Full Text] [Related]
22. Five-year experience with metallic stents for chronic ureteral obstruction.
Kadlec AO; Ellimoottil CS; Greco KA; Turk TM
J Urol; 2013 Sep; 190(3):937-41. PubMed ID: 23485505
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of a novel, double-layered, coated, self-expandable metallic mesh stent (Uventa™) in malignant ureteral obstructions.
Chung KJ; Park BH; Park B; Lee JH; Kim WJ; Baek M; Han DH
J Endourol; 2013 Jul; 27(7):930-5. PubMed ID: 23590584
[TBL] [Abstract][Full Text] [Related]
24. A Prospective Randomized Comparison of a Covered Metallic Ureteral Stent and a Double-J Stent for Malignant Ureteral Obstruction.
Kim JW; Hong B; Shin JH; Park J; Kim JH; Gwon DI; Ryu MH; Ryoo BY
Korean J Radiol; 2018; 19(4):606-612. PubMed ID: 29962867
[TBL] [Abstract][Full Text] [Related]
25. [Management of ureteral obstruction : Value of percutaneous nephrostomy and ureteral stents].
Netsch C; Becker B; Gross AJ
Urologe A; 2016 Nov; 55(11):1497-1510. PubMed ID: 27787581
[TBL] [Abstract][Full Text] [Related]
26. Multicenter experience with metallic ureteral stents for malignant and chronic benign ureteral obstruction.
Modi AP; Ritch CR; Arend D; Walsh RM; Ordonez M; Landman J; Gupta M; Knudsen BE
J Endourol; 2010 Jul; 24(7):1189-93. PubMed ID: 20575695
[TBL] [Abstract][Full Text] [Related]
27. Single-Center Experience with Three Metallic Ureteral Stents (Allium
Khoo CC; Ho C; Palaniappan V; Ting A; Forster L; Kondjin-Smith M; Abboudi H; Hanna M; El-Husseiny T; Dasgupta R
J Endourol; 2021 Dec; 35(12):1829-1837. PubMed ID: 34074131
[No Abstract] [Full Text] [Related]
28. Long-Term Outcomes of Double-Layered Polytetrafluoroethylene Membrane-Covered Self-Expandable Segmental Metallic Stents (Uventa) in Patients with Chronic Ureteral Obstructions: Is It Really Safe?
Kim M; Hong B; Park HK
J Endourol; 2016 Dec; 30(12):1339-1346. PubMed ID: 27736158
[TBL] [Abstract][Full Text] [Related]
29. The Role of Tandem Double-J Ureteral Stents in the Management of Malignant Ureteral Obstruction.
Varnavas M; Bolgeri M; Mukhtar S; Anson K
J Endourol; 2016 Apr; 30(4):465-8. PubMed ID: 26585189
[TBL] [Abstract][Full Text] [Related]
30. Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.
Matsuura H; Arase S; Hori Y
Int J Clin Oncol; 2019 Mar; 24(3):306-312. PubMed ID: 30298199
[TBL] [Abstract][Full Text] [Related]
31. Ureteroiliac artery fistula caused by full-length metallic ureteral stenting in a malignant ureteral obstruction: a case report.
Miyauchi Y; Osaki Y; Naito H; Tsunemori H; Itoh M; Kanenishi K; Norikane T; Sanomura T; Nishiyama Y; Sugimoto M
J Med Case Rep; 2020 Oct; 14(1):195. PubMed ID: 33070773
[TBL] [Abstract][Full Text] [Related]
32. Risk Factors for Primary Failure of Metallic Ureteral Stents: Experience from a Tertiary Center.
Hsu JS; Huang CY; Liu KL; Chow PM
J Endourol; 2021 Jun; 35(6):912-918. PubMed ID: 29325432
[No Abstract] [Full Text] [Related]
33. Outcomes of indwelling metallic stents for malignant extrinsic ureteral obstruction.
Asakawa J; Iguchi T; Tamada S; Ninomiya N; Kato M; Yamasaki T; Nakatani T
Int J Urol; 2018 Mar; 25(3):258-262. PubMed ID: 29194771
[TBL] [Abstract][Full Text] [Related]
34. Prediction of Stent Failure for Malignant Ureteral Obstruction in Non-Urological Cancer.
Heo JE; Jeon DY; Lee J; Han HH; Jang WS
Yonsei Med J; 2023 Nov; 64(11):665-669. PubMed ID: 37880847
[TBL] [Abstract][Full Text] [Related]
35. Malignant ureteral obstruction: comparison of metallic, 8 French and 6 French ureteric stents after failure of initial ureteric stent.
Ong K; Chen J; Kong J; Kuan M
World J Urol; 2024 Feb; 42(1):92. PubMed ID: 38386090
[TBL] [Abstract][Full Text] [Related]
36. The management of malignant ureteral obstruction treated with ureteral stents.
Ganatra AM; Loughlin KR
J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
[TBL] [Abstract][Full Text] [Related]
37. Clinical outcomes and prognostic factors associated with internal ureteral stent placement for malignant extrinsic ureteral obstruction.
Matsuura H; Arase S; Hori Y
Support Care Cancer; 2020 Dec; 28(12):5743-5750. PubMed ID: 32206969
[TBL] [Abstract][Full Text] [Related]
38. Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients.
Liu KL; Lee BC; Ye JD; Chang YH; Chang CC; Huang KH; Lee YJ; Chang YC
Eur Radiol; 2019 Feb; 29(2):628-635. PubMed ID: 29974220
[TBL] [Abstract][Full Text] [Related]
39. A systematic review of long-duration stents for ureteral stricture: which one to choose?
Corrales M; Doizi S; Barghouthy Y; Kamkoum H; Somani B; Traxer O
World J Urol; 2021 Sep; 39(9):3197-3205. PubMed ID: 33386951
[TBL] [Abstract][Full Text] [Related]
40. Metallic stent in the treatment of ureteral obstruction: experience of single institute.
Li CC; Li JR; Huang LH; Hung SW; Yang CK; Wang SS; Chen CS; Ou YC; Ho HC; Su CK; Chen WM; Cheng CL; Yang CR; Chiu KY
J Chin Med Assoc; 2011 Oct; 74(10):460-3. PubMed ID: 22036138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
